Sanuwave Health (NASDAQ:SNWV - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "buy" rating to a "hold" rating in a research note issued on Saturday.
Other equities analysts have also recently issued research reports about the stock. Weiss Ratings restated a "sell (d-)" rating on shares of Sanuwave Health in a research report on Wednesday. Northland Capmk upgraded shares of Sanuwave Health to a "strong-buy" rating in a research report on Wednesday, September 3rd. Northland Securities initiated coverage on shares of Sanuwave Health in a research report on Wednesday, September 3rd. They set an "outperform" rating and a $55.00 target price for the company. Finally, Roth Capital set a $53.00 target price on shares of Sanuwave Health and gave the stock a "buy" rating in a research report on Tuesday. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $54.00.
View Our Latest Research Report on SNWV
Sanuwave Health Stock Up 0.2%
Shares of NASDAQ SNWV opened at $32.26 on Friday. Sanuwave Health has a 52 week low of $5.63 and a 52 week high of $46.58. The firm has a 50-day moving average price of $37.48 and a 200 day moving average price of $33.77. The stock has a market capitalization of $276.47 million, a price-to-earnings ratio of -3.91 and a beta of 1.33.
Sanuwave Health (NASDAQ:SNWV - Get Free Report) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.10. The company had revenue of $10.16 million during the quarter, compared to analyst estimates of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.
Institutional Investors Weigh In On Sanuwave Health
A number of institutional investors have recently bought and sold shares of the stock. Legal & General Group Plc purchased a new stake in Sanuwave Health in the second quarter valued at approximately $26,000. Strategic Investment Solutions Inc. IL acquired a new position in Sanuwave Health during the first quarter valued at approximately $47,000. BNP Paribas Financial Markets acquired a new position in Sanuwave Health during the second quarter valued at approximately $46,000. Police & Firemen s Retirement System of New Jersey acquired a new position in Sanuwave Health during the second quarter valued at approximately $52,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Sanuwave Health during the second quarter worth $102,000. 42.53% of the stock is currently owned by hedge funds and other institutional investors.
About Sanuwave Health
(
Get Free Report)
SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Sanuwave Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sanuwave Health wasn't on the list.
While Sanuwave Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
